Pavel Rodyukov
Director/Board Member at PHARMSYNTHEZ
Profile
Pavel Rodyukov is the founder of Binx Health, Inc. founded in 2005.
He is currently the Chairman of NovaMedica LLC, Director of OcuNexus Therapeutics, Inc., Director of Pharmsynthez PJSC starting in 2023, Director of Trackpore Technology CJSC, Director of RMI Partners OOO, and Director of OCON Medical Ltd.
He has previously worked as a Director at Celtaxsys, Inc. and as an Investment Director at RUSNANO Projects.
Pavel Rodyukov active positions
Companies | Position | Start |
---|---|---|
PHARMSYNTHEZ | Director/Board Member | 2023-08-02 |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Director/Board Member | - |
Trackpore Technology CJSC
Trackpore Technology CJSC Medical/Nursing ServicesHealth Services Trackpore Technology CJSC provides medical equipment for membrane plasmapheresis. It offers cycle of production from development to manufacture of equipment and consumables for procedures of membrane plasmapheresis and cascade plasma filtration. The company was founded in 1998 and is headquartered in Moscow, Russia. | Director/Board Member | - |
OCON Medical Ltd.
OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Director/Board Member | - |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Director/Board Member | - |
NovaMedica LLC
NovaMedica LLC Pharmaceuticals: MajorHealth Technology NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation. | Chairman | - |
Former positions of Pavel Rodyukov
Companies | Position | End |
---|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Director/Board Member | - |
binx health, inc.
binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Founder | - |
RUSNANO Projects
RUSNANO Projects Investment ManagersFinance Rusnano Projects is a private equity and venture capital operating division of the State-owned Rusnano OJSC. The firm was founded in 2007 and is headquartered in Moscow, Russia. | Private Equity Investor | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PHARMSYNTHEZ | Health Technology |
Private companies | 8 |
---|---|
RUSNANO Projects
RUSNANO Projects Investment ManagersFinance Rusnano Projects is a private equity and venture capital operating division of the State-owned Rusnano OJSC. The firm was founded in 2007 and is headquartered in Moscow, Russia. | Finance |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Finance |
Trackpore Technology CJSC
Trackpore Technology CJSC Medical/Nursing ServicesHealth Services Trackpore Technology CJSC provides medical equipment for membrane plasmapheresis. It offers cycle of production from development to manufacture of equipment and consumables for procedures of membrane plasmapheresis and cascade plasma filtration. The company was founded in 1998 and is headquartered in Moscow, Russia. | Health Services |
OCON Medical Ltd.
OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Health Services |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Health Technology |
NovaMedica LLC
NovaMedica LLC Pharmaceuticals: MajorHealth Technology NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation. | Health Technology |
binx health, inc.
binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Pavel Rodyukov